Catumaxomab

immunoglobulin G2a, anti-(human antigen 17-1A) (mouse monoclonal Ho-3/TP-A-01/TPBs01 heavy chain), disulfide with mouse monoclonal Ho-3/TP-A-01/TPBs01 light chain, disulfide with immunoglobulin G2b anti-(human CD3(antigen))(rat monoclonal 26/II/6-1.2/TPBs01 heavy chain), disulfide with rat monoclonal 26/II/6-1.2/TPBs01 light chain